Kamran Tavangar Takes Charge as Head of Science Strategy at LabCentral

LabCentral's New Head of Science Strategy: Kamran Tavangar

In a significant move for the biotech community, LabCentral has announced the appointment of Kamran Tavangar as its Head of Science Strategy. This newly created executive position focuses on optimizing LabCentral's scientific direction, thereby enhancing offerings for its residents and the wider innovation ecosystem. Kamran brings with him over 30 years of robust experience, having navigated leadership roles across multinational pharmaceutical firms and biotech start-ups.

A Seasoned Expert in Biotech

Tavangar's prior credentials are nothing short of impressive. He has held key positions at Novartis, including leading Strategic Planning for Novartis Pharma, overseeing Oncology operations in Australia, and managing Global Marketing for Novartis Vaccines. Additionally, he played an instrumental role as co-founder and COO at Affinivax, a notable venture in the vaccine sector, and was also the CEO of Atias Pharma, focusing on therapeutics. His expansive educational background includes an MBA from MIT Sloan School of Management, a PhD in Physiology from Stanford University, and an undergraduate degree in Molecular Biology from the University of California, Berkeley.